Showing results (2281-2290 of 2,661) with videos related to

Sort By:
Pageof 267
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 23, 2023
SIRT6 pharmacological inhibition delays skin cancer progression in the squamous cell carcinomaElena Abbotto, Caterina Miro, Francesco Piacente, et al.
Women'S Health (London, England)|July 14, 2026
Elinzanetant for the Treatment of Menopausal Hot Flashes: A Plain Language Review of the OASIS-1-4 Clinical Trial ResultsJoAnn V Pinkerton, Rossella E Nappi, Claudio N Soares, et al.
Cephalalgia : an International Journal of Headache|July 10, 2018
Economic benefits of treating medication-overuse headache - results from the multicenter COMOESTAS projectPernille Linde Jellestad, Louise Ninett Carlsen, Maria Lurenda Westergaard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2013
Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cellsTeresa Troiani, Erika Martinelli, Stefania Napolitano, et al.
Journal of Personalized Medicine|April 3, 2021
Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New ResultsTeresa Troiani, Stefania Napolitano, Gabriella Brancaccio, et al.
Radiation Oncology (London, England)|August 28, 2012
Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinomaPiernicola Pedicini, Antonio Nappi, Lidia Strigari, et al.
Endocrine-Related Cancer|August 25, 2012
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinomaRoberto Bellelli, Maria Domenica Castellone, Ginesa Garcia-Rostan, et al.
The Laryngoscope|December 21, 2023
Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life StudyFrancesco Giombi, Gian Marco Pace, Emanuele Nappi, et al.
BMJ Open|June 28, 2026
Virtual reality training for cognitive impairment in adults treated with haemodialysis (VIRTUAL): protocol for a multicentre, randomised, open-label feasibility trialDavide Viggiano, Giovanni Pellegrino, Patrizia Natale, et al.
Rheumatology International|June 1, 2017
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and CanadaLaure Weijers, Christoph Baerwald, Francesco S Mennini, et al.
Pageof 267